Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF)

Market Cap	8.08B -7.6%
Revenue (ttm)	39.43B +3.0%
Net Income	792.98M +40.2%
EPS	0.21 +41.6%
Shares Out	n/a
PE Ratio	10.19
Forward PE	11.11
Dividend	0.06 (3.93%)
Ex-Dividend Date	Dec 29, 2025

Volume	100
Average Volume	15,574
Open	1.460
Previous Close	1.530
Day's Range	1.460 - 1.460
52-Week Range	1.180 - 1.618
Beta	0.39
RSI	49.35
Earnings Date	Mar 30, 2026

About SHPMF

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as in...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1994
• Employees: 49,402
• Stock Exchange: OTCMKTS
• Ticker Symbol: SHPMF

Financial Performance

In 2024, SHPMF's revenue was 275.25 billion, an increase of 5.75% compared to the previous year's 260.30 billion. Earnings were 4.55 billion, an increase of 20.82%.

Financial numbers in CNY